title: Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
authors.forename: Andrew
authors.initials: A
authors.lastname: Blitzer
authors.forename: Mitchell F
authors.initials: MF
authors.lastname: Brin
authors.forename: Celia F
authors.initials: CF
authors.lastname: Stewart
mesh_terms: D019274:Botulinum Toxins, Type A / Q000266:history* / Q000627:therapeutic use; D055154:Dysphonia / Q000188:drug therapy / Q000266:history*; D005500:Follow-Up Studies; D049673:History, 20th Century; D006801:Humans; D007273:Injections, Intramuscular / Q000266:history; D009465:Neuromuscular Agents / Q000266:history* / Q000627:therapeutic use; D014481:United States
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A